Article Details

Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding

Retrieved on: 2024-10-13 01:22:31

Tags for this article:

Click the tags to see associated articles and topics

Japanese startup Alpha Fusion accelerates astatine-based drug discovery with Series B funding. View article details on hiswai:

Summary

The article discusses Alpha Fusion's funding to enhance its development of Astatine-based cancer therapies for global markets, leveraging chemical elements and synthetic elements in targeted alpha-particle therapy, with significant backing from SBI Investment Co. Ltd.

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up